Under the deal, Genoptix will also secure one million shares of NeoGenomics common stock. Located in Carlsbad of California, Genoptix is specialized in hematology and solid tumor testing
The post NeoGenomics to buy Genoptix for $125m appeared first on Compelo Medical Devices.
Original Article: NeoGenomics to buy Genoptix for $125m